Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents

Eur Child Adolesc Psychiatry. 2011 Dec;20(11-12):597-8. doi: 10.1007/s00787-011-0215-z. Epub 2011 Sep 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Analysis of Variance
  • Antipsychotic Agents / adverse effects*
  • Aripiprazole
  • Attention Deficit and Disruptive Behavior Disorders / drug therapy
  • Benzodiazepines / adverse effects
  • Bipolar Disorder / drug therapy
  • Body Mass Index*
  • Body Weight / drug effects*
  • Child
  • Dibenzothiazepines / adverse effects
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mental Disorders / drug therapy
  • Olanzapine
  • Piperazines / adverse effects
  • Quetiapine Fumarate
  • Quinolones / adverse effects
  • Risperidone / adverse effects
  • Schizophrenia / drug therapy
  • Spain
  • Time Factors

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Piperazines
  • Quinolones
  • Benzodiazepines
  • Quetiapine Fumarate
  • Aripiprazole
  • Risperidone
  • Olanzapine